MedTrace Logo

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP

NCT05401201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2026-04-17

No results posted yet for this study

Summary

This study is designed to investigate the effectiveness of plaque control intervention by home-use dual-light aPDT Lumoral -device as an adjunctive or alternative treatment to triamcinolone acetonide (TCA) mouth rinse or other topical corticosteroid treatment on the symptoms and clinical appearance of symptomatic gingival involvement of oral lichen planus (OLP).

Conditions

  • Oral Lichen Planus
  • Dental Plaque
  • Oral Bacterial Infection

Interventions

DEVICE

Lumoral treatment

The investigational Lumoral treatment -device provides a constant and repeatable application which can be done at home and is easily available. All subjects in the study group will receive their own Lumoral treatment -device and Lumorinse-mouth rinse tablets for the complete duration of the study.

OTHER

Standard oral hygiene self care

Both groups shall be given oral and written instructions for twice-daily standard oral hygiene self care.

Sponsors & Collaborators

  • Wellbeing Services County of Pirkanmaa

    collaborator OTHER

  • Tampere University

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Koite Health Oy

    lead INDUSTRY

Principal Investigators

  • Tommi Pätilä, Docent · Chief Medical Officer

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-24
Primary Completion
2026-04-01
Completion
2026-04-13

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05401201 on ClinicalTrials.gov